Real-world efficacy of adjuvant single-agent intravesical gemcitabine for non-muscle invasive bladder cancer.

MLA

Abou Chakra, Mohamad, et al. “Real-World Efficacy of Adjuvant Single-Agent Intravesical Gemcitabine for Non-Muscle Invasive Bladder Cancer.” Expert Opinion on Pharmacotherapy, vol. 24, no. 18, Sept. 2023, pp. 2081–91. EBSCOhost, https://doi.org/10.1080/14656566.2023.2271396.

APA

Abou Chakra, M., Packiam, V. T., & O’Donnell, M. A. (2023). Real-world efficacy of adjuvant single-agent intravesical gemcitabine for non-muscle invasive bladder cancer. Expert Opinion on Pharmacotherapy, 24(18), 2081–2091. https://doi.org/10.1080/14656566.2023.2271396

Chicago

Abou Chakra, Mohamad, Vignesh T Packiam, and Michael A O’Donnell. 2023. “Real-World Efficacy of Adjuvant Single-Agent Intravesical Gemcitabine for Non-Muscle Invasive Bladder Cancer.” Expert Opinion on Pharmacotherapy 24 (18): 2081–91. doi:10.1080/14656566.2023.2271396.